Vol. 29 (2) 2022 – 09

  Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 76–86. www.Ejimmunology.org https://doi.org/10.55133/eji.290209...

Vol. 29 (2) 2022 – 08

  Pooled-Testing for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction (RT-PCR) in asymptomatic healthcare workers in EL-Raghy isolation COVID-19 hospital, Assiut University The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 68–75....

Vol. 29 (2) 2022 – 07

Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 57–67. www.Ejimmunology.org https://doi.org/10.55133/eji.290207 Shaymaa...

Vol. 29 (2) 2022 – 06

Does herpes simplex virus have a role in the pathogenesis of systemic lupus erythematosus in Egyptians? The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 48–56. www.Ejimmunology.org https://doi.org/10.55133/eji.290206 Tarek T. H. ElMelegy1, Amany H....

Vol. 29 (2) 2022 – 05

Comparison of Histidine rich glycoprotein, a novel biomarker for sepsis, with traditional biomarkers in adult ICU patients The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 41–47. www.Ejimmunology.org https://doi.org/10.55133/eji.290205 Mohammed A....

Vol. 29 (2) 2022 – 04

Serum clusterin as a promising diagnostic and prognostic marker for hepatocellular carcinoma after locoregional treatment The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 26–40. www.Ejimmunology.org https://doi.org/10.55133/eji.290204 Hany S....